Mednet Logo
HomeQuestion

What prostate cancer patient population would benefit from a brachytherapy boost after EBRT without the use of ADT?

2
1 Answers
Mednet Member
Mednet Member
Radiation Oncology · Case Western Reserve University/ University Hospitals Seidman Cancer Center

The paper referenced in the question for better or worse is the best evidence we have regarding the benefit we can expect from a brachy boost, the benefit we can expect from the addition of ADT to EBRT, and if you were to compare EBRT+ADT vs EBRT+brachy. It shows that adding ADT has an OS benefit co...

Register or Sign In to see full answer